Stock comparison
Repligen
RGEN
Market cap
$6.9B
Sector
Healthcare
Overall winner
Thermo Fisher Scientific
RGEN 0–6 TMO
Thermo Fisher Scientific
TMO
Market cap
$175.7B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
RGENvsTMO
39D
52C
69D
74B
40D
40D
13F
28F
43D
51D
39D
52D
42D
45D
Side-by-side metrics
| Metric | RGEN | TMO |
|---|---|---|
| Market cap | $6.9B | $175.7B |
| P/E (TTM) | 123.0x | 26.4x |
| EV/EBIT | 108.0x | 27.2x |
| ROIC (TTM) | 2.18% | 7.33% |
| Gross margin | 50.25% | 39.41% |
| Net margin | 6.73% | 15.18% |
| Revenue CAGR 5y | 2.43% | 3.25% |
| EPS CAGR 5y | -21.83% | -2.43% |
| Debt / Equity | 0.3x | 0.8x |
| Dividend yield | 0.0% | 0.36% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RGEN leads on
- Debt / Equity0.3xvs 0.8x+61%
- Gross margin50.25%vs 39.41%+22%
TMO leads on
- Dividend yield0.36%vs 0.0%+100%
- Market cap$175.7Bvs $6.9B+96%
- EPS CAGR 5y-2.43%vs -21.83%+89%
- P/E (TTM)26.4xvs 123.0x+79%
More like RGEN
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.